Skip to content

Seroepidemiology of Viral Hepatitis in Hong Kong

Evaluation of the Seroepidemiology of Hepatitis A and B in the General Population for Informing the Development of New Hepatitis Vaccination Strategies in Hong Kong

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04371276
Enrollment
2888
Registered
2020-05-01
Start date
2018-09-01
Completion date
2022-05-31
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral Hepatitis

Keywords

hepatitis A, hepatitis B, epidemiology

Brief summary

Immunisation policies have strong influences on the epidemiology of hepatitis A and B infection. In Hong Kong, vaccines against both viruses have been available through different channels and programmes in the past 3 decades. To evaluate the changes in the prevalence of hepatitis A and B in the general population, a seroepidemiology study is conducted involving a prospective cross-sectional survey followed for serology testing. Eligible members of 1327 spatially random households would be invited to join the study by completing a questionnaire and providing blood samples, either by dried blood spots or venesection, for determining the presence of antigen and/or antibody against hepatitis B, as well as antibody against hepatitis A. The main measures comprise a set of metrics on the prevalence of hepatitis A and B. Analysis would be conducted to examine the association of risk factors with the tested markers and describe the attitudes towards viral hepatitis vaccination. The results would allow us to understand the transmission potential of hepatitis A and B in the community would be influenced by the changing disease epidemiology and coverage of vaccination, which inform the development of new vaccination strategies in Hong Kong

Interventions

OTHERNo intervention

Blood samples will be collected from recruited subjects from invited households for testing for hepatitis B (HBsAg, anti-HBs and anti-HBc) and hepatitis A (anti-HAV)

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* residents normally living in Hong Kong * living in domestic households randomly selected from Building Groups * Any age, while subjects below the age of 18 would require informed consent of their guardians for participation * Any gender

Exclusion criteria

* unable to understand written Chinese or English, * failure to give consent for participation * living in institution or non-domestic housing, * foreign domestic helpers, * normally living in Hong Kong

Design outcomes

Primary

MeasureTime frameDescription
hepatitis B infection prevalence12 monthsProportion of individuals with positive HBsAg
hepatitis A immunity prevalence12 monthsProportion of individuals with positive IgG against HAV

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026